EN DE
STOCK COMPARISON

Omada Health, Inc. Common Stock vs Veeva Systems Inc Class A: Fair Value & Quality

Both stocks run through our valuation models. Here is how Omada Health, Inc. Common Stock (OMDA) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Omada Health, Inc. Common Stock trades at $23.67 versus a fair value of $7.44 (-69%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Omada Health, Inc. Common Stock
OMDA · USD · Health Care
-69%
upside to fair value
overvalued
Price$23.67
Fair Value$7.44
Quality58/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-59%
upside to fair value
overvalued
Price$230
Fair Value$95.12
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Omada Health, Inc. Common StockVeeva Systems Inc Class A
Valuation
P/E (TTM)33.6×
3.70×P/S (TTM)9.31×
4.57×P/B4.28×
EV/EBITDA28.7×
PEG0.85×
Profitability
-2%Net margin28%
-6%Operating margin31%
-4%Return on equity14%
-2%Return on assets7%
Growth
42%Revenue growth (YoY)16%
42.9%Avg. growth/yr (3Y)14.0%
Avg. growth/yr (5Y)16.9%
Balance & size
0.13×Debt / equity
$1BMarket cap$31B
mixedGrowth qualityhealthy

Veeva Systems Inc Class A leads: 3 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Omada Health, Inc. Common Stockof which business quality 63 · market factors 56 Veeva Systems Inc Class Aof which business quality 72 · market factors 48
ProfitabilityMargins and returns on capital today
33
57
Quality GrowthAre margins and returns improving?
80
65
CashflowEarnings quality: real cash, not paper profit
56
93
Fin. StrengthBalance sheet, leverage, solvency risk
98
91
InvestmentDisciplined investing over empire-building
58
33
Low VolatilityCalm price path (market factor)
2
55
MomentumPrice trend over the last 3–12 months (market factor)
86
52
52W MomentumDistance to the 52-week high (market factor)
69
31
Net IssuanceBuybacks instead of dilution
50
72

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Omada Health, Inc. Common Stock

DCF Models$8.89
Multiples$6.94
Asset-Based$2.59
Growth DCF$9.43

7 of 7 models see the stock below the current price.

Veeva Systems Inc Class A

DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185

21 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Omada Health, Inc. Common Stock
Bear $6.33Fair Value $7.44Bull $8.55
$23.67 = current price (white tick)
Veeva Systems Inc Class A
Bear $71.34Fair Value $95.12Bull $146
$230 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Omada Health, Inc. Common Stock · Health Care

Quality score58 · above median
Fair value upside-69% · bottom 25%

Veeva Systems Inc Class A · Health Care

Quality score72 · Top 25%
Fair value upside-59% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Omada Health, Inc. Common Stock trades at $23.67 versus a fair value of $7.44 (-69%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).

Veeva Systems Inc Class A has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.